Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1 1

Status

Recruiting 55Active not recruiting 16Completed 14Terminated 5Not yet recruiting 3Withdrawn 1Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Genitourinary 5Gastrointestinal 4Thoracic 1Gynecologic 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 41Breast Neoplasms 31Neoplasms 28Neoplasm Metastasis 23Melanoma 20Leukemia, Myeloid, Acute 20Prostatic Neoplasms 19Colorectal Neoplasms 17Multiple Myeloma 16Lung Neoplasms 16Recurrence 13Myelodysplastic Syndromes 13Squamous Cell Carcinoma of Head and Neck 12Lymphoma, Non-Hodgkin 12Carcinoma, Renal Cell 12Ovarian Neoplasms 11Lymphoma, Large B-Cell, Diffuse 11Carcinoma, Hepatocellular 11Urinary Bladder Neoplasms 10Uterine Cervical Neoplasms 9Pancreatic Neoplasms 9Glioblastoma 9Head and Neck Neoplasms 8Stomach Neoplasms 7Rectal Neoplasms 7Lymphoma, Follicular 7Glioma 7Brain Neoplasms 7Solid Tumor 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6

Interventions

Radiotherapy 1Palliative Care 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × Kidney Neoplasms × 90 days × Clear all
NCT05861947 2026-04-17

JIVAN

Aurigene Discovery Technologies Limited

Phase 1 Terminated
21 enrolled
GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Colonic Neoplasms, Esophageal Neoplasms, Kidney Neoplasms, Recurrence, Stomach Neoplasms

NCT06760702 2026-04-17

TEJAS-2

Aurigene Discovery Technologies Limited

Phase 2 Terminated
29 enrolled
GastrointestinalGenitourinaryGynecologic

Kidney Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT03846128 2026-04-14

BIOSUNTOX

University Hospital, Rouen

Terminated
6 enrolled
Genitourinary

Kidney Neoplasms

NCT02439008 2026-03-13

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

Centre Oscar Lambret

Phase NA Terminated
28 enrolled
DermatologicGastrointestinalGenitourinary

Carcinoma, Hepatocellular, Kidney Neoplasms, Melanoma, Colorectal Neoplasms

NCT03652298 2026-03-13

NeuroPrevPTSD

Centre Oscar Lambret

Phase 2 Terminated
19 enrolled
GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Kidney Neoplasms, Neoplasms, Prostatic Neoplasms, Stress Disorders, Post-Traumatic, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡